Genetics Institute and Affymetrix in technology access deal:
This article was originally published in Clinica
Participants in Genetics Institute's DiscoverEase programme - a library of secreted proteins and genes - are to have access to Affymetrix's GeneChip technology for expression analysis under a three-year agreement. Under the deal, GI will also build, and sell access to, a database of gene expression patterns to users of DiscoverEase. The two companies also announced the successful completion of a three-year collaboration using DNA chips for high-throughput gene expression monitoring.
You may also be interested in...
The UK has approved the mRNA-based vaccine just nine days after receiving the final Phase III results from Pfizer.
As the MHRA prepares to grant approval to the Oxford/AstraZeneca vaccine, Wockhardt is set to supply 100 million doses for the UK government’s own use and its WHO commitments. The company is also in talks with global vaccine developers to manufacture their COVID-19 vaccines for emerging economies
A combined final opinion on the European Chemicals Agency’s proposed microplastic restriction is expected from ECHA committees by year-end, at which point the European Commission will consider whether and when microplastic must be removed from all leave-on cosmetic products marketed in the EU.